IMVT IMMUNOVANT INC
2026Q1 · CUSIP 45258J102 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
215
Δ holders QoQ
+18
Breadth percentile
Top 17%
Whale holders
118
Δ whales
+17
Inst. holding value
$2.7B
New positions
46
Closed positions
28
Price momentum (1Q)
+1.0%
Put / Call
6/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 11 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 17% | — | — |
| 2025Q3 | Top 20% | +8.5% | +46.3% |
| 2023Q4 | Top 11% | -17.3% | -16.1% |
| 2023Q3 | Top 4% | +11.2% | -8.5% |
| 2023Q1 | Top 18% | -7.2% | +62.1% |
| 2022Q4 | Top 18% | +18.7% | +14.5% |
| 2022Q3 | Top 6% | +38.1% | +59.7% |
| 2021Q3 | Top 18% | -31.0% | -54.4% |
Options Sentiment
Put holders
6
QoQ: 0
Call holders
6
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.77
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-59.3%
Debt ratio
10.9%
FCF (TTM)
-$407M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.